Effect of a Cardiac Rehabilitation Program on Chronic Heart Failure Patients in Yaoundé, Cameroon

NCT ID: NCT04790214

Last Updated: 2021-03-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-01

Study Completion Date

2021-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

CARECA-CHF study is a non-randomized, prospective, single-arm study, enrolled ambulatory patients with stable chronic heart failure \[New York Heart Association (NYHA) class II/III\]. Patients will be followed-up during a period of 06-08 weeks. The aim of this study is to assess the effect of a cardiac rehabilitation program on patients with stable chronic heart failure in Yaoundé, Cameroon.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

CARECA-CHF study is a non-randomized, prospective, single-arm study, multicentric study. Patients with stable chronic heart failure \[New York Heart Association (NYHA) class II/III\] will be enrolled ambulatory. The program will take place during a period of 06-08 weeks.

The aim of this study is to assess the effect of a cardiac rehabilitation program on patients with stable chronic heart failure in a resource-limited country.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Heart Failure (CHF)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Patients with stable CHF in stage II or III of the New York Heart Association.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stable CHF patients

Stable CHF patients on stage II/III based on the New York Heart Failure classification

Group Type EXPERIMENTAL

CHF Patients

Intervention Type OTHER

Cardiac rehabilitation program on CHF patients on 06-08 weeks. Program will include: physical aerobic re-training, therapeutic education on CHF, psychological follow-up, nutritional education

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CHF Patients

Cardiac rehabilitation program on CHF patients on 06-08 weeks. Program will include: physical aerobic re-training, therapeutic education on CHF, psychological follow-up, nutritional education

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with stable chronic heart failure confirmed by a cardiac ultrasound and whose severity is rated stage II or III of NYHA followed at Yaoundé central hospital and Yaoundé general hospital;
* Stable under treatment;
* Whose cardiac ultrasound is less than six months old;
* Having given his free and informed consent.

Exclusion Criteria

* Poor adherence to the cardiac rehabilitation program activities;
* Patients lost insight the program;
* Withdrawal of informed consent.
Minimum Eligible Age

21 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yaounde Central Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

CN NGANOU-GNINDJIO, MD, MSc

Dr, Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chris Nadège N Nganou-Gnindjio, MD, MAS

Role: PRINCIPAL_INVESTIGATOR

Yaounde Central Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dr Chris Nadège Nganou-Gnindjio

Yaoundé, , Cameroon

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Cameroon

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CARECA-CHF

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cardiac Rehabilitation in Chagas Heart Failure
NCT02516293 COMPLETED PHASE2/PHASE3